Respiratorius AB Company Description

Respiratorius AB (publ), a research company, develops pharmaceuticals for the treatment of cancer.

Its products under development include VAL001, that is in Phase III clinical trials for the treatment of diffuse large B-cell lymphoma; and VAL001, a product candidate that is in preclinical phase for the treatment of relapsing diffuse large B-cell lymphoma.

The company was incorporated in 1998 and is based in Lund, Sweden.

Respiratorius AB (publ)

Country	Sweden
Founded	1998
Industry	Biological Products, Except Diagnostic Substances
Employees	0
CEO	Johan Drott

Contact Details

Address: Medicon Village Lund, 223 81 Sweden
Phone	46 7 09 22 41 40
Website	respiratorius.com

Stock Details

Ticker Symbol	RESP
Exchange	Spotlight Stock Market
Share Class	Class A Shares
Fiscal Year	January - December
Reporting Currency	SEK
ISIN Number	SE0023314315
SIC Code	2836

Key Executives

Name	Position
Johan Drott	Chief Executive Officer